Tomer Kariv - Director, Keros Therapeutics, Inc

As of June 3, 2021

Tomer Kariv Net Worth

  • Net worth is estimated to be at least $15.1M
  • Owns at least 155,262 units of Keros Therapeutics, Inc stock

Tomer Kariv Trading

  • Largest purchase of shares was 3,982,599 units , worth over $7M on April 13, 2020
  • In total has made about 3 transactions over a year
  • Usually trades in November, June and April, with the busiest year in 2020

Tomer Kariv
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Tomer Kariv Mailing Address

  • Mailing address is C/o Arno Therapeutics, Inc. 200 Route 31 North, Suite 104 Flemington NJ 08822 NJ

Keros Therapeutics, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Jasbir Seehra, Ph.D. 2020 $521,014 $8,713,137 $262,650 $3,498 $9,500,299
Jasbir Seehra, Ph.D. 2019 $485,100 $15,379 $194,040 - $694,519
Keith Regnante 2020 $323,170 $1,901,352 $138,000 $521 $2,363,042
Jennifer Lachey, Ph.D. 2020 $370,196 $3,017,362 $154,200 $521 $3,542,278
Jennifer Lachey, Ph.D. 2019 $294,255 $27,039 $93,000 - $414,294
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1664710/000110465921051967/tm2112429-1_def14a.htm

Keros Therapeutics, Inc Insider Trading

  • The most recent transaction was 5,300 units sold on May 13, 2022 by Jennifer Lachey worth over $222.05K
  • In the last 2 years, insiders at Keros Therapeutics, Inc sold an estimated value of $34.03M and bought an estimated value of $46.24M
  • The most active traders are Jennifer Lachey, Chief Scientific Officer,  Julius Knowles, Director,  and Claudia Ordonez, Chief Medical Officer
  • Insider trading is most common in April, with the busiest year in 2021

Keros Therapeutics, Inc. Insider Trades
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1